Hepatitis C Activities Within CSTE Defining Core Surveillance for - - PowerPoint PPT Presentation

Defining Core Surveillance for HCV and Building The Capacity to Sustain It

Hepatitis C Activities Within CSTE

Brooke Beaulieu, MPH NASTAD Technical Assistance Meeting Washington, DC | November 2017

• CS

CSTE TE: An An or

• rganiz

ization ional l ov

• vervie

iew

• Who are we?
• What do we do?
• What resources are available to you?
• Ac

Activities specific to He Hepat atitis C

• HCV Subcommittee
• Future opportunities
• Mo

Movin ing forward: Increasin ing capacit ity and natio ional l pa partnerships ps t to pr provide de t technical a assistance a and d sup support

• How do we define core surveillance for HCV?
• What needs have been identified through previous discussions?
• Where do we go from here?

Roadmap

The 10 Essential Public Health Services

1.

• 1. Mo

Monitor Health to Identify and Solve Com Community y Health Prob

• blems
• Accurate, periodic assessment of

community’s health status

• Use of methods and technology to

interpret and communicate data

• Maintenance of population health

registries and data management systems 2.

• 2. Di

Diag agnose an and Investigat ate Heal alth Pr Problems ms in the Commu mmunity

• Timely identification and

investigation of health threats

• Availability of diagnostic services,

including laboratory capacity

• Developing response plans and

guidance to address health threats

https://www.cdc.gov/stltpublichealth/index.html

CSTE: Who Are We?

Community of Practice Sharing Knowledge to Create Best Practices Harmonization and Standardization Liaisons and Partnership across All Levels of Practice Advocacy for Data-Driven Policy Capacity Building

Organizational Structure

Infectious Disease Chronic/ MCH/Oral

EH/ Occupational/ Injury Surveillance/ Informatics

Cross Cutting I Cross Cutting II

Enteric Disease HAI Hepatitis C Influenza & Other Viral Respiratory HIV STD Vector-borne Disease Vaccine- Preventable

Chronic Disease Maternal & Child Health Oral Health

Climate Change

Disaster Epi

Environmental Epi Injury Surveillance & Control Occupational Health Electronic Lab and Disease Reporting Surveillance Policy Surveillance Practice and Implementation Alcohol Epi Alcohol and Other Drug Indicators Marijuana Mental Health Overdose Prescription Drug Monitoring Substance Use

Border/ International Health Health Disparities Epi Methods Public Health Emergency Prep Public Health Law Tribal Epi Workforce

• Regular subcommittee calls to discuss current and

emerging issues

• Workgroups and task forces to develop guidance,

products, and deliverables

• Consultant opportunities
• In-person meetings, workshops, and trainings
• Workforce development, capacity building, and

fellowship programs

• CSTE Annual Conference
• Development and revision of case definitions for

standardized surveillance and national notification

Broad Overview of Activities

• Each June, CSTE convenes its annual meeting
• Topical tracks closely mirror our Steering Committee and

Subcommittee focus areas

• At a glance: Boise 2017
• Last year, close to 1600

1600 registered attendees.

• 16

16 workshops across various program areas

• Over 900

900 total presentations

• Culmination at the CSTE Business Meeting
• Voting on position statements
• Executive Board torch-passing

CSTE Annual Conference

CS CSTE 2018

• West Palm Beach, Florida
• June 10th – 14th
• Call for abstracts now
• pen!

More information at www.csteconference.org

CSTE Annual Conference

Position Statements

• Represent the documentation and analysis of policy issues

affecting public health and that are of interest to CSTE members

• Types of Position Statements
• Policy
• Standardized Surveillance for Diseases or Conditions
• Standardized Surveillance for Healthcare-Associated

Diseases or Conditions through the National Healthcare Safety Network

• Authored by active CSTE members and voted on by full

membership at the CSTE Annual Conference

Position Statements

• 2015:

2015: 15-ID-03 “Revision to the Case Definition of Hepatitis C for National Notification.”

• 2016:

2016: 16-ID-06 “Public Health Reporting and National Notification of Perinatal Hepatitis B Virus Infection.”

• 2017:

2017: 17-ID-08 “Public Health Reporting and National Notification of Perinatal Hepatitis C Virus Infection.” Al All posi siti tion n statem statements ents can an be e ac accessed essed at at www www.cs cste.org

• St

Steer eering ng Committee ee and nd Sub Subcommittee ee calls

• Over 1800

1800 members collectively sharing insights, experiences, and information

• Me

Mentoring opportuniti ties

• St

Strong ng partner nershi hips with h CDC and nd other her association n organi nizations ns

• Opportunities to inform national guidance
• Creating a network for technical assistance opportunities
• In

Increased opportunity for collaboration across programmatic and ju juris isdic ictio ional l lin ines

Community of Practice Network

• Ap

Applie ied Epid idemio iolo logy Fello lowship ip (AE AEF)

• Currently, 45 fellows in the field
• Placed in programs spanning infectious

disease, behavioral health, maternal and child health, and more.

• In

Informat atics t trai aining

• Project SHINE fellowships
• Informatics Training-in-Place assignees
• Pe

Peer-to to-Pe Peer r consulta tatio ions

Capacity Building Assistance

• The He

Hepatitis C (HC HCV) Sub Subcommittee ee is comprised of a group of epidemiologists, program coordinators, and others interested in hepatitis C surveillance and epidemiology

• The pu

purpo pose of the subcommittee is to inform and improve practices related to HC HCV surveillance and data analysis in local, state, tribal and territorial settings.

• The mi

mission of the HCV subcommittee is to promote and support collaboration, communication, innovation, dissemination, and evaluation of data among public health professionals to in info form and enhance HC HCV surveillance

HCV Subcommittee

• Regular calls the fi

first Thursday of f every month (3:00 PM ET)

• 2015 HCV Surveillance Capacity Assessment
• Workgroups to develop case definitions and standardized

guidance

• Advocacy letters
• Responding to requests for information
• Regular partner updates from DVH and NASTAD
• Annual conference activities
• Hepatitis-focused track
• ”Defining core surveillance for HCV”
• “Collision course: The intersection between substance

abuse and infectious disease”

HCV Specific Activities

• Sub

Subst stanc nce e use use and nd beha ehavioral hea health h program area eas

• State-based grants
• Crosscutting collaborative efforts
• Sur

Survei eillanc nce e and nd inf nformatics

• Updates to Message Mapping Guides (MMG)
• Electronic laboratory reporting

Areas of Collaboration Within CSTE

How do we define what it means to conduct core surveillance for HCV?

• Resources (capacity, funding, data) and current practices for

conducting HCV surveillance vary significantly across jurisdictions

• Strong need to develop standardized guidance, best practices,

and continued knowledge sharing

• Emphasis on the need for strong national guidance to inform

recommendations and practice

• Increased opportunities for technical assistance and capacity

building support in state, local, territorial, and tribal health agencies

Emergent Themes

• Full day HCV workshop at CSTE Annual Conference:

Ju June 10th

th, 2

, 2018

• Collaborative effort between CSTE, NASTAD, and DVH

to address current surveillance needs to works toward HCV elimination

• HCV care cascades
• Impact of and uniformly applying the 2016 HCV case definition
• Perinatal HCV surveillance
• Efficiencies and best practices
• Sp

Sponso nsorshi ship assi ssist stanc nce e for up to 25 viral hepatitis surveillance coordinators to attend the workshop and conference in full

Moving Forward: Next Steps for Core Surveillance

Questions to Ponder

• In

In a resource ce co constrained program area, how do we leve verage exi xisting resources (c (capacity ty, f , fund unding ng, d , data ta) ) to to:

• Identify and respond in a timely, impactful way to public health threats
• Ensure sustainability within programs
• Communicate effectively to multiple audiences
• Demonstrate the evidence necessary to successfully advocate for

appropriate resources

• Wh

What types of f technical assistance do you fe feel are most neces necessary t y to co cond nduct uct H HCV CV s sur urvei veillance i nce in yo n your ur j jur urisdicti ction? n?

• How can CSTE and our partners provide that TA?
• Ho

How do we ensure that these conversations progress in a way tha that ul ulti timatel ely y sup upports jur urisdicti ctions ns?

• CSTE Subcommittee members, Dan Church (MA)
• CDC Division of Viral Hepatitis
• NASTAD staff

A Note of Appreciation

CST CSTE Nationa nal Office

2872 Woodcock k Boulevard, Suite 250 At Atlanta, Georgia 30341 770. 770.458. 458.3811 3811 770. 770.458. 458.8516 8516 brooke ke@cste.org

F T

Questions?